Equity Capital Markets

Company · CIK 1646102

Theravance Biopharma Antibiotics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1646102 (SEC EDGAR)
Incorporated inE9
Business addressCayman Islands
Listedno ticker on SEC record today
First annual or quarterly reportnone on EDGAR

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-205275-06
ShelfEffective
2015-06-262015-07-162

Filings

2
FiledFilingRegistrationAccession
2015-07-16EFFECTDeclared effective 333-205275-069999999995-15-001956
2015-06-26S-3Shelf registered 333-205275-060001047469-15-005813

All filings of this company · CSV